Tetanus Infections and Infestations Tetanus
Conditions
Interventions
Patients entered into the study were randomised to receive:
1. Benzylpenicillin 2 million units (child 25,000 units/kg) IV six-hourly for seven days
2. Metronidazole 1
Sponsors
University of Oxford (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Clinical diagnosis of tetanus 2. Aged more than one month 3. Informed consent from patient or attendant relative (if comatose or aged less than 16 years)
Exclusion criteria
Exclusion criteria: Lack of informed consent or age less than one month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint was mortality. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints were recovery times and complication rates. | — |
Countries
Bangladesh, Thailand
Outcome results
None listed